Literature DB >> 18592380

Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.

Gursharanjit Singh1, Bijaya Ghosh, Dave Kaushalkumar, Vanita Somsekhar.   

Abstract

The objective of the study was to investigate in vitro transdermal delivery of venlafaxine hydrochloride across the pigskin by passive diffusion and iontophoresis. For passive diffusion, experiments were carried out in Franz diffusion cell whereas for iontophoretic permeation, the diffusion cell was modified to contain both the donor and return electrode on the same side of skin. Anodal iontophoresis was carried out using a current density of 0.5 mA/cm(2). Donor concentrations used were 585.5 mg/ml (saturated solution) and 100 mg/ml. Experiments initially performed to determine the transport efficiency of venlafaxine ions showed promising results. Iontophoresis increased the permeation rate at both concentration levels over their passive counterparts (P < 0.01), but surprisingly higher steady-state flux was obtained from lower donor drug load (P < 0.01). The favorable pH of the unsaturated solutions is suggested to be the cause for this effect. Mild synergistic effect was observed when iontophoresis was carried out incorporating peppermint oil in the donor but the same was not found in passive diffusion. Highest steady-state flux obtained in the experiment was 3.279 mumol/cm(2)/h when peppermint oil (0.1%) was included in the donor. As the maintenance requirement of venlafaxine hydrochloride is approximately 9.956 mumol/h, the results suggested that the drug is a promising candidate for iontophoretic delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18592380      PMCID: PMC2977036          DOI: 10.1208/s12249-008-9111-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  37 in total

1.  Effect of physicochemical parameters on skin permeability of antihypertensive.

Authors:  B Ghosh; L H Reddy
Journal:  Indian J Exp Biol       Date:  2001-07       Impact factor: 0.818

2.  Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients.

Authors:  J Alexander Bodkin; Jay D Amsterdam
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

Review 3.  Optimizing outcomes in depression: focus on antidepressant compliance.

Authors:  M B Keller; R M A Hirschfeld; K Demyttenaere; D S Baldwin
Journal:  Int Clin Psychopharmacol       Date:  2002-11       Impact factor: 1.659

Review 4.  Rationale and options for the long-term treatment of depression.

Authors:  Martin B Keller
Journal:  Hum Psychopharmacol       Date:  2002-06       Impact factor: 1.672

5.  Venlafaxine in neuropathic pain following treatment of breast cancer.

Authors:  Tiina Tasmuth; Brita Härtel; Eija Kalso
Journal:  Eur J Pain       Date:  2002       Impact factor: 3.931

6.  Characterization of the iontophoretic permselectivity properties of human and pig skin.

Authors:  D Marro; R H Guy; M B Delgado-Charro
Journal:  J Control Release       Date:  2001-01-29       Impact factor: 9.776

7.  Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.

Authors:  M Matoga; F Pehourcq; K Titier; F Dumora; C Jarry
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-09-05

8.  Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes.

Authors:  Amit Kumar Jain; Narisetty Sunil Thomas; Ramesh Panchagnula
Journal:  J Control Release       Date:  2002-02-19       Impact factor: 9.776

9.  Venlafaxine in the treatment of premenstrual dysphoric disorder.

Authors:  E W Freeman; K Rickels; K A Yonkers; N R Kunz; M McPherson; G V Upton
Journal:  Obstet Gynecol       Date:  2001-11       Impact factor: 7.661

10.  Transport numbers in transdermal iontophoresis.

Authors:  Blaise Mudry; Richard H Guy; M Begoña Delgado-Charro
Journal:  Biophys J       Date:  2006-01-27       Impact factor: 4.033

View more
  5 in total

1.  Venlafaxine HCl Encapsulated in Niosome: Green and Eco-friendly Formulation for the Management of Pain.

Authors:  Seyyed Mohammad Hassan Hashemi; Reza Enayatifard; Jafar Akbari; Majid Saeedi; Mohammad Seyedabadi; Katayoun Morteza-Semnani; Amirhossein Babaei; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2022-05-20       Impact factor: 3.246

2.  Transdermal delivery of venlafaxine hydrochloride: the effects of enhancers on permeation across pig ear skin.

Authors:  C Vijaya; Manasa Bingi; L V Vigneshwaran
Journal:  Indian J Pharm Sci       Date:  2011-07       Impact factor: 0.975

3.  Synergistic Effect and Mechanism of Cineole and Terpineol on In-vitro Transdermal Delivery of Huperzine A from Microemulsions.

Authors:  Jun Shi; Wen-Juan Cong; Yi-Ming Wang; Qing-Fei Liu; Guo-An Luo
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

4.  5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model.

Authors:  Mingrong Cheng; Bing He; Tao Wan; Weiping Zhu; Jiang Han; Bingbing Zha; Houxiang Chen; Fengxiao Yang; Qing Li; Wei Wang; Hongzhi Xu; Tao Ye
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

5.  In vitro and In vivo characterization of the transdermal delivery of sertraline hydrochloride Films.

Authors:  R Vijaya; K Ruckmani
Journal:  Daru       Date:  2011       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.